메뉴 건너뛰기




Volumn 31, Issue 5, 2012, Pages 543-

Gonococcal septic shock associated with eculizumab treatment

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DOPAMINE; ECULIZUMAB; HEMOGLOBIN; MENINGOCOCCUS VACCINE; MEROPENEM; NORADRENALIN; VANCOMYCIN;

EID: 84860244540     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182503849     Document Type: Letter
Times cited : (18)

References (5)
  • 1
    • 60649118722 scopus 로고    scopus 로고
    • Eculizumab for paroxysmal nocturnal haemoglobinuria
    • Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet. 2009;373:759-767.
    • (2009) Lancet , vol.373 , pp. 759-767
    • Parker, C.1
  • 2
    • 52949136616 scopus 로고    scopus 로고
    • FDA report: Eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria
    • Dmytrijuk A, Robie-Suh K, Cohen MH, et al. FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Oncologist. 2008; 13:993-1000.
    • (2008) Oncologist , vol.13 , pp. 993-1000
    • Dmytrijuk, A.1    Robie-Suh, K.2    Cohen, M.H.3
  • 3
    • 41349089713 scopus 로고    scopus 로고
    • Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
    • Brodsky RA, Young NS, Antonioli E, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;111:1840-1847.
    • (2008) Blood , vol.111 , pp. 1840-1847
    • Brodsky, R.A.1    Young, N.S.2    Antonioli, E.3
  • 4
    • 81155154243 scopus 로고    scopus 로고
    • Eculizumab: A review of its use in paroxysmal nocturnal haemoglobinuria
    • McKeage K. Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria. Drugs. 2011;71:2327-2345.
    • (2011) Drugs , vol.71 , pp. 2327-2345
    • McKeage, K.1
  • 5
    • 77949469955 scopus 로고    scopus 로고
    • The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
    • Kelly R, Richards S, Hillmen P, et al. The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab. Ther Clin Risk Manag. 2009;5:911-921.
    • (2009) Ther Clin Risk Manag , vol.5 , pp. 911-921
    • Kelly, R.1    Richards, S.2    Hillmen, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.